Zdrowie i gospodarka · 21/10/2009

FDA Publishes Guidance for Cardiac Allograft Gene Expression Profiling Test Systems

The FDA has released a guidance document outlining requirements for cardiac allograft gene expression profiling test systems, which are classified as Class II devices, to ensure compliance with special controls and labeling regulations.